• Pfizer Acquires Therachon, Looks To Add To Rare Disease Pipeline

    Pfizer acquires private biotech Therachon to gain a clinical product, known as TA-46, to treat patients with Achondroplasia. Pfizer paid an upfront …

    Read More
  • 0 0